Roche Holding Ltd's Form 4 filing
Jasper Therapeutics, Inc. (JSPR) · filed Jan 26, 2023
- Accession no.
- 0001104659-23-007094
- Filed
- Jan 26, 2023, 5:49 PM ET
- Trade date
- Jan 25, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $141.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roche Holding LtdCIK 0000889131 | 10% Owner |
| Roche Finance LtdCIK 0001053942 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | Voting Common Stock | SSaleDisposed | −75,000 | $1.89 | −$141,750 | 4,549,606 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.